According to filings with the U.S. Securities and Exchange Commission, ArriVent Biopharma is raising $175,000,000.00 in new funding. About ArriVent Biopharma: ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. With a…
According to filings with the U.S. Securities and Exchange Commission, ArriVent Biopharma is raising $145,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Zhengbin Yao played a key…
Newtown Square, PA – According to filings with the U.S. Securities and Exchange Commission, ArriVent Biopharma is raising $150,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Zhengbin…
Newtown Square, PA – According to filings with the U.S. Securities and Exchange Commission, ArriVent Biopharma is raising $90,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Zhengbin…